Exploring the anticancer potential of green silver Nanoparticles–Paclitaxel nanocarrier on MCF-7 breast Cancer cells: an in vitro approach
Abstract Paclitaxel (PTX) is a potent chemotherapeutic agent limited by poor solubility and adverse effects. To address these challenges, we developed a novel nanocomposite combining PTX purified from the endophytic fungus A. fumigatiaffinis PP235788.1 with biosynthesized silver nanoparticles (AgNPs...
Saved in:
| Main Authors: | M. Bassam Aboul-Nasr, Alaa A. Yasien, Sabah S. Mohamed, Yahya Bassam Aboul-Nasr, Marwa Obiedallah |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-06275-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of albumin-bound paclitaxel versus paclitaxel in esophageal cancer: a systematic review and meta-analysis
by: Jiayang Song, et al.
Published: (2025-08-01) -
Nanoparticle albumin-bound paclitaxel – first step of nanotechnology into clinical practice
by: R. N. Alyautdin, et al.
Published: (2022-06-01) -
Circular RNAs: key regulators of paclitaxel sensitivity and resistance in cancer
by: Zahra Tajik, et al.
Published: (2025-08-01) -
Harnessing nature: plant-derived nanocarriers for targeted drug delivery in cancer therapy
by: Esther Ugo Alum, et al.
Published: (2025-08-01) -
Emerging trends and global collaboration in Paclitaxel resistance research for breast cancer: a comprehensive bibliometric study
by: Yuxuan Meng, et al.
Published: (2025-08-01)